Nalmefene hydrochloride

Immunogen Synthetic peptide directed towards the middle region of human CHRNB2 Biochem/physiol Actions Mutations in nAChRs are found in a rare form of nocturnal frontal lobe epilepsy . Previously, some nAChR mutations have been described that are

Immunogen Synthetic peptide directed towards the middle region of human CHRNB2 Biochem/physiol Actions Mutations in nAChRs are found in a rare form of nocturnal frontal lobe epilepsy . Previously, some nAChR mutations have been described that

General description Neuronal acetylcholine receptor subunit alpha-4 (UniProt P43681: also known as alpha4 nAChR subunit, cholinergic receptor, nicotinic, alpha polypeptide 4, nAChR alpha4 subunit, Neuronal nicotinic acetylcholine receptor alpha-4

Neuropilin and tolloid-like protein 1, also known as Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 1, and encoded by the gene name NETO1 or BTCL1, is involved in the development and/or maintenance

ASP2535 is a potent, selective, brain permeable and centrally-active glycine transporter-1 (GlyT1) inhibitor.ASP2535 can improve cognitive impairment in animal models of schizophrenia and Alzheimer's disease.

α5IA (L-822179) is a selective α5 GABAA receptor inverse agonist with neuroprotective potential.

α5IA (L-822179) is a selective α5 GABAA receptor inverse agonist with neuroprotective potential.

α5IA (L-822179) is a selective α5 GABAA receptor inverse agonist with neuroprotective potential.

α5IA (L-822179) is a selective α5 GABAA receptor inverse agonist with neuroprotective potential.

α5IA (L-822179) is a selective α5 GABAA receptor inverse agonist with neuroprotective potential.

α5IA (L-822179) is a selective α5 GABAA receptor inverse agonist with neuroprotective potential.

Canertinib (CI-1033) is a pan-ErbB inhibitor for EGFR and ErbB2 with IC50 of 1.5 nM and 9.0 nM, no activity to PDGFR, FGFR, InsR, PKC, or CDK1/2/4.An irreversible pan-erbB tyrosine kinase inhibitor.